Clinical Trials and Research Studies
Clinical Trials
-
Natural History Study of Synucleinopathies
Stanford is currently accepting patients for this trial. -
Bright Light as a Countermeasure for Circadian Desynchrony
Stanford is currently accepting patients for this trial.
More Studies
Applying 3D Upper Airway Ultrasound Imaging to Clinical Diagnosis of Obstructive Sleep Apnea
Purpose: To “see” the airway: how it collapses during snoring for our patients with obstructive sleep apnea remains a challenge. At Stanford, we started a study using ultrasound imaging to “see” your airway in a non-invasive manner without radiation.
PI: Clete Kushida, MD, PhD / Stanley Liu, MD, DDS
Study status: Open, enrollment ongoing
Coordinator Contact:
Neehar Thumaty
neehart@stanford.edu
(650)721-7574
Sleep and Oxygen Levels
Makoto Kawai, MD, D.Sc.
Purpose: to participate in groundbreaking research examining sleep and measures of brain oxygen levels simultaneously.
Payment offered for participation
Time needed from participant:
- Spend 6-8 hours of active participation
- You will be asked to complete one sleep assessment (polysomnography)
To qualify, you must:
- Be a healthy individual, 60+ years old
- Be able to travel to Stanford to complete some questionnaires
Coordinator Contact:
Isabelle Cotto (650) 723-2795
ijoly@Stanford.edu
Upper Airway Training for OSA
Clete Kushida, MD, PhD
Purpose: To see if playing a musical instrument-training program can improve OSA
Inclusion:
- 21-50 years old
- Diagnosis of mild to moderate OSA
- HST scheduled or recently performed
Time needed from participant: Approximately 12 weeks depending on OSA severity
Coordinator Contact:
Adrian Ekelmans (650) 721-5489
adrian01@stanford.edu
UVN-G3031 for Narcolepsy 1 or 2
Emmanuel Mignot, MD, PhD
Purpose: To study the safety and efficacy of study drug SUVN-G3031 as a possible treatment for NT1 and NT2
Inclusion:
- 18-50 years old
- Diagnosis of narcolepsy type 1 or 2
- MSLT within 15 years showing ≤ 8 minutes with 2 or more SOREMPs
- An ESS score of ≥ 12
Time needed from participant: Up to 7 weeks of active participation. At least 5 clinic visits during that period
Coordinator Contact:
Vivian Liu (650) 721-5489
vivian44@stanford.edu
Blood biomarkers study in REM sleep behavior disorder (RBD)
Purpose: studying neuroinflammation and immune protective factors in patients with RBD
Co-PI: Emmanuel Mignot, MD, PhD
Study status: Open, enrollment ongoing
Research Coordinator:
Ana Cahuas (research coordinator) 650 721 5489, acahuas@stanford.edu
Home diagnosis of REM sleep behavior disorder (RBD) using wearable sleep trackers
Purpose: developing a machine learning method to diagnose RBD in the home environment with wrist-worn actigraphy
Study status: Open, enrollment ongoing
Research Coordinator:
Ana Cahuas (research coordinator) 650 721 5489, acahuas@stanford.edu
For more information: https://www.ClinicalTrials.gov
Participant’s right questions, contact: 1-866-680-2906